BAFF and its receptors:contribution and therapeutic potential in atherosclerosis

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1025211

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Atherosclerosis is an inflammatory reaction to cholesterol in blood vessels. Despite cholesterol-lowering statins, atherosclerosis-based heart attacks and strokes remain a major cause of deaths. Studies of BAFF, a pro-inflammatory molecule can shed new light on the inflammation. As BAFF blockers are already in clinical trials to treat inflammatory diseases, our study has potential to lead to using BAFF blockers to treat human atherosclerosis.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2014

Funding Scheme: Project Grants

Funding Amount: $562,742.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cardiology (incl. Cardiovascular Diseases)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

atherosclerosis | cardiovascular disease | immunology | inflammation | lymphocytes

Related Links